Skip to content

Pacing in Cardiac Magnetic Resonance Imaging: a CRT trial

Pacing in Cardiac Magnetic Resonance Imaging: a CRT trial - PICARIA-CRT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47190
Enrollment
10
Registered
2018-05-03
Start date
2019-02-20
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure

Interventions

CRT candidates will receive a full CMR examination prior to device implantation. Six weeks after CRT-D implantation, CMR imaging will be repeated during intrinsic rhythm and biventricular pacing. Su

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients need to fulfil the 2013 guideline of the European Society of Cardiology criteria for cardiac pacing and cardiac resynchronisation therapy. In order to participate in this study, a subject must meet all of the following criteria: - Chronic heart failure - New York Heart Association (NYHA) functional class II, III or ambulant IV - QRS duration * 120ms - Left bundle branch block - Optimal pharmacological therapy - LV ejection fraction * 35% - Sinus rhythm

Exclusion criteria

Exclusion criteria: The exclusion criteria applying for this study are: - Age

Design outcomes

Primary

MeasureTime frame
The main study parameter is CMR cine image quality, quantified by grading 17 LV segments on a 5-point grading scale (grade 1 is excellent and 5 non-diagnostic). Image quality will be compared post- versus pre-implantation. Quantitative LV functional and volumetric CMR parameters will be determined during intrinsic rhythm and during biventricular stimulation, this will be compared to pre-implantation CMR measurements (intrinsic rhythm) and invasive measurements (biventricular stimulation).

Secondary

MeasureTime frame
To reach the secondary objectives, the following parameters will be evaluated : 1. Comparison of quantitative CMR parameters post- versus pre-implantation. These parameters are derived from cine (LV mass), tagging (regional strain, torsion, dyssynchrony, discoordination), phase contrast imaging (cardiac output, diastolic function, mitral regurgitation volume) and DCE (scar mass, scar localization) images. During the post-implantation CMR examination additional LV lead localisation will be performed. See chapter 6.2.1. for detailed CMR scan protocol. 2. Comparison of quantitative CMR parameters during CRT on versus CRT off. Functional parameters derived from cine images (LV volumes / EF, LV mass), tagged images (regional strain, torsion, dyssynchrony, discoordination) and phase contrast imaging (cardiac output, diastolic function, mitral regurgitation volume) will be compared. See chapter 6.2.1. for detailed outline. 3. Relation between baseline dyssynchrony, discoordination and (wasted) work, their changes in response to CRT and pump function improvement before and after device optimization. During the invasive study, pump function is determined by Stroke work (SW), directly calculated as the area of the pressure-volume loop. The effect of biventricular pacing is calculated as the relative SW change compared with the mean of the two flanking baseline measurements. Changes in dyssynchrony, discoordination and work parameters are related to changes in SW. See chapter 6.2.1 for details on the CMR scan protocol and chapter 6.2.3. for details on the invasive study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)